Papgene, Inc.

Biotechnology company · Baltimore, Maryland, United States

Papgene, Inc. is a biotechnology company headquartered in Baltimore, Maryland, United States. Its earliest recorded incorporation is in 2014. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $5.2 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2015.

Profile compiled from public records. Is this your company? Request a correction or update

Papgene at a glance

Typebiotechnology company
HeadquartersBaltimore, Maryland, United States
Earliest incorporation on record2014
Employees (self-reported, 2017)3
SEC CIK1634570

What does Papgene do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $5.2 million in total (2016 to 2017). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $3 million sold (2015).

Frequently asked questions about Papgene

Where is Papgene headquartered?

Papgene, Inc. is headquartered in Baltimore, Maryland, United States.

What does Papgene do?

Papgene, Inc. is a biotechnology company.

When was Papgene founded?

The earliest incorporation on record for Papgene, Inc. is in 2014, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences